» Authors » Erich Vinicius De Paula

Erich Vinicius De Paula

Explore the profile of Erich Vinicius De Paula including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 540
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moraes C, Mayr E, De Paula E
Hematol Transfus Cell Ther . 2024 Dec; 46 Suppl 5:S1-S2. PMID: 39617536
No abstract available.
2.
Barbosa M, de Lima F, Moraes C, Borba-Junior I, Huber S, Santos I, et al.
Front Med (Lausanne) . 2024 May; 11:1367544. PMID: 38803346
Coagulation activation in immunothrombosis involves various pathways distinct from classical hemostasis, offering potential therapeutic targets to control inflammation-induced hypercoagulability while potentially sparing hemostasis. The Angiopoietin/Tie2 pathway, previously linked to embryonic...
3.
Borba-Junior I, Lima F, Vitoria Rodrigues Oliveira D, Moraes C, Annichino-Bizzacchi J, Bombassaro B, et al.
Res Pract Thromb Haemost . 2023 Jun; :100282. PMID: 37361399
Introduction: Podoplanin ( gene) and CLEC-2 are involved in inflammatory hemostasis and have also been related with the pathogenesis of thrombosis. Emerging evidence also suggest that podoplanin can exert protective...
4.
Cardoso Jacintho B, Mazetto Fonseca B, Hounkpe B, Oliveira J, Dos Santos A, de Oliveira Vaz C, et al.
Front Med (Lausanne) . 2023 Apr; 10:1139906. PMID: 37035297
Thrombotic primary antiphospholipid syndrome (t-PAPS) is an acquired condition characterized by heterogeneous thrombotic manifestations, which is intriguing since venous and arterial thrombosis appear to have distinct pathogenesis. Gene expression analysis...
5.
Moraes C, Borba-Junior I, de Lima F, Silva J, Bombassaro B, Palma A, et al.
Front Physiol . 2023 Mar; 14:1113968. PMID: 36895630
Endothelial barrier (EB) disruption contributes to acute lung injury in COVID-19, and levels of both VEGF-A and Ang-2, which are mediators of EB integrity, have been associated with COVID-19 severity....
6.
de Lima F, Moraes C, Barbosa M, Bombassaro B, Palma A, Dertkigil S, et al.
Exp Biol Med (Maywood) . 2023 Feb; 248(4):309-316. PMID: 36740756
Heme-oxygenase 1 (HO-1) is an enzyme with well-known anti-inflammatory and antioxidant properties, whose levels have been previously associated with disease severity in the context of sterile and infectious diseases. Moreover,...
7.
Montalvao S, de Moraes Martinelli B, da Silva Souza Gois G, Huber S, De Paula E, Annichino-Bizzacchi J
Int J Lab Hematol . 2022 Nov; 45(2):e43-e46. PMID: 36372983
No abstract available.
8.
Castro J, Appenzeller S, Colella M, Yamaguti-Hayakawa G, De Paula E, Annichinno-Bizzachi J, et al.
PLoS One . 2022 Sep; 17(9):e0272290. PMID: 36129939
Background And Purpose: Thrombotic microangiopathy (TMA) is a group of microvascular occlusive disorders that presents with neurological involvement in up to 87% of the cases. Although the central nervous system...
9.
Hounkpe B, Moraes C, Lanaro C, Santos M, Costa F, De Paula E
Exp Biol Med (Maywood) . 2022 Jul; 247(17):1542-1547. PMID: 35775605
Hemolytic diseases such as Sickle Cell Disease (SCD) are characterized by a natural propensity for both arterial and venous thrombosis. The ability of heme to induce tissue factor (TF) activation...
10.
Mazetto B, Hounkpe B, da Silva Saraiva S, Vieira-Damiani G, Dos Santos A, Jacinto B, et al.
Thromb Res . 2022 May; 214:132-137. PMID: 35561448
Background: The release of neutrophil extracellular traps (NETs) is the basis of immune-mediated thrombosis. Data on the clinical relevance of NETs in antiphospholipid syndrome-related thrombosis are scarce. Objective: The aim...